73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Body fat percentage vs. BMI: Which is important?

Body fat percentage vs. BMI: Which is important?

by Taylor Barnes,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainThe start of a new year for many means the start of a new health and fitness journey. Claire Edgemon, senior registere

Body fat percentage vs. BMI: Which is important?

by Taylor Barnes,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainThe start of a new year for many means the start of a new health and fitness journey. Claire Edgemon, senior registere
Study highlights difficulty in diagnosing blood disorders, need for coordination between clinicians and pathologists

Study highlights difficulty in diagnosing blood disorders, need for coordination between clinicians and pathologists

by University of Miami Leonard M. Miller School of Medicine“Our findings highlight the vital importance of seeking expert opinions from National Cancer Institute-designated cancer centers, especi

Study highlights difficulty in diagnosing blood disorders, need for coordination between clinicians and pathologists

by University of Miami Leonard M. Miller School of Medicine“Our findings highlight the vital importance of seeking expert opinions from National Cancer Institute-designated cancer centers, especi
Imaging after one week on pembrolizumab may predict treatment response in advanced melanoma

Imaging after one week on pembrolizumab may predict treatment response in advanced melanoma

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainImaging the tumors of patients with advanced melanoma receiving pembrolizumab (Keytruda) after only one week—rather tha

Imaging after one week on pembrolizumab may predict treatment response in advanced melanoma

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainImaging the tumors of patients with advanced melanoma receiving pembrolizumab (Keytruda) after only one week—rather tha
Evaluation of ruxolitinib, a JAK inhibitor, in multiple myeloma

Evaluation of ruxolitinib, a JAK inhibitor, in multiple myeloma

by Impact Journals LLCRuxolitinib exerts its anti-myeloma effects through several mechanisms. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28547A new research perspective titled &quot

Evaluation of ruxolitinib, a JAK inhibitor, in multiple myeloma

by Impact Journals LLCRuxolitinib exerts its anti-myeloma effects through several mechanisms. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28547A new research perspective titled &quot
Estrogen-negative cancers respond to anti-estrogenic therapies, study shows

Estrogen-negative cancers respond to anti-estrogenic therapies, study shows

byHokkaido UniversityCredit: Nabeel KajiharaAnti-estrogenic therapies can suppress the growth of cancer that does not express estrogen receptors; when combined with immune checkpoint inhibitor t

Estrogen-negative cancers respond to anti-estrogenic therapies, study shows

byHokkaido UniversityCredit: Nabeel KajiharaAnti-estrogenic therapies can suppress the growth of cancer that does not express estrogen receptors; when combined with immune checkpoint inhibitor t
Efficacy shown for new melanoma therapeutic vaccine

Efficacy shown for new melanoma therapeutic vaccine

by Physician's Briefing StaffIn a recent trial, a new melanoma vaccine, mRNA-4157 (V940), when taken in combination with Keytruda (pembrolizumab), was found to be effective in battling the deadly

Efficacy shown for new melanoma therapeutic vaccine

by Physician's Briefing StaffIn a recent trial, a new melanoma vaccine, mRNA-4157 (V940), when taken in combination with Keytruda (pembrolizumab), was found to be effective in battling the deadly
Researchers identify promising drug to treat gastrointestinal cancers

Researchers identify promising drug to treat gastrointestinal cancers

by Joe Dangor,Mayo ClinicCredit: Unsplash/CC0 Public DomainGastrointestinal cancers are some of the most commonly diagnosed cancers, and they continue to be associated with poor survival outcome

Researchers identify promising drug to treat gastrointestinal cancers

by Joe Dangor,Mayo ClinicCredit: Unsplash/CC0 Public DomainGastrointestinal cancers are some of the most commonly diagnosed cancers, and they continue to be associated with poor survival outcome
Results of trial will help guide treatment of malignant bowel obstruction in patients with advanced cancer

Results of trial will help guide treatment of malignant bowel obstruction in patients with advanced cancer

by SWOG Cancer Research NetworkCredit: CC0 Public DomainFindings from the first-ever prospective trial including a randomized pathway comparing surgery to non-surgical treatment of malignant bowel obs

Results of trial will help guide treatment of malignant bowel obstruction in patients with advanced cancer

by SWOG Cancer Research NetworkCredit: CC0 Public DomainFindings from the first-ever prospective trial including a randomized pathway comparing surgery to non-surgical treatment of malignant bowel obs
Bacterium may decrease effectiveness of immunotherapy

Bacterium may decrease effectiveness of immunotherapy

by Béatrice St-Cyr-Leroux,University of MontrealAssociation between the H. pylori seropositivity status and clinical outcomes in 97 patients with advanced melanoma. A. Stacked barplot between H.

Bacterium may decrease effectiveness of immunotherapy

by Béatrice St-Cyr-Leroux,University of MontrealAssociation between the H. pylori seropositivity status and clinical outcomes in 97 patients with advanced melanoma. A. Stacked barplot between H.
Preventing 'chemo brain' with antioxidants targeting the spinal fluid

Preventing 'chemo brain' with antioxidants targeting the spinal fluid

by Children's Hospital BostonGraphical abstract. Credit:Neuron(2022). DOI: 10.1016/j.neuron.2022.08.009Up to three quarters of patients receiving cancer chemotherapy suffer from &

Preventing 'chemo brain' with antioxidants targeting the spinal fluid

by Children's Hospital BostonGraphical abstract. Credit:Neuron(2022). DOI: 10.1016/j.neuron.2022.08.009Up to three quarters of patients receiving cancer chemotherapy suffer from &
Research provides insight into genetic link to potential treatment response among BRCA1/2 breast cancer patients

Research provides insight into genetic link to potential treatment response among BRCA1/2 breast cancer patients

by Alex Gardner,Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainNew findings from researchers in the Perelman School of Medicine at the University of Pennsy

Research provides insight into genetic link to potential treatment response among BRCA1/2 breast cancer patients

by Alex Gardner,Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainNew findings from researchers in the Perelman School of Medicine at the University of Pennsy
New drug combinations could improve therapies for breast cancer, other aggressive cancers

New drug combinations could improve therapies for breast cancer, other aggressive cancers

by Angela Yeager,Oregon Health & Science UniversityQuantification of CD8+T cells by multispectral flow cytometry in an ex vivo co-culture assay. Credit:Cell Reports Medicine&nbsp

New drug combinations could improve therapies for breast cancer, other aggressive cancers

by Angela Yeager,Oregon Health & Science UniversityQuantification of CD8+T cells by multispectral flow cytometry in an ex vivo co-culture assay. Credit:Cell Reports Medicine&nbsp